Low Rates of HPV Vaccination and Cervical Cancer Screening: Challenges and Opportunities in the Context of the COVID-19 Pandemic

Overview

Journal Prev Med

Specialty Public Health

Date 2022 Apr 24

PMID 35461955

Authors

Debi L Smith

Rebecca B Perkins

Affiliations

Soon will be listed here.

Abstract

This invited commentary discusses the article by Richards et al. describing differences in rates of on-time HPV vaccination and cervical cancer screening in 2018 among enrollees in different insurance plans. The commentary focuses on the larger problem of low vaccination HPV rates and decreasing cervical cancer screening rates seen across all sectors. We outline challenges posed by the COVID-19 pandemic on HPV vaccination and cervical cancer screening, and discuss opportunities to improve cervical cancer prevention.

Citing Articles

Early adoption of innovation in HPV prevention strategies: closing the gap in cervical cancer.

Mahajan I, Kadam A, McCann L, Ghose A, Wakeham K, Dhillon N Ecancermedicalscience. 2024; 18:1762.

PMID: 39430092 PMC: 11489098. DOI: 10.3332/ecancer.2024.1762.

Empowering Women's Health: Insights Into HPV Vaccination and the Prevention of Invasive Cervical Cancer.

Rathod S, Potdar J, Gupta A, Sethi N, Dande A Cureus. 2023; 15(11):e49523.

PMID: 38156129 PMC: 10752828. DOI: 10.7759/cureus.49523.

Text messaging intervention for Pap smear uptake: a single-institution study.

Bhardwaj N, Herndon A, Kuo Y, Porterfield L Mhealth. 2023; 9:34.

PMID: 38023781 PMC: 10643222. DOI: 10.21037/mhealth-23-11.

Knowledge, Attitudes and Practices of Women in the UAE Towards Breast and Cervical Cancer Prevention: A Cross-Sectional Study.

Elbarazi I, Alam Z, Abdullahi A, Al Alawi S, AlKhanbashi M, Rabaa A Cancer Control. 2023; 30:10732748231211459.

PMID: 37950611 PMC: 10640807. DOI: 10.1177/10732748231211459.

Examining the perceived impact of the COVID-19 pandemic on cervical cancer screening practices among clinicians practicing in Federally Qualified Health Centers: A mixed methods study.

Fuzzell L, Lake P, Brownstein N, Fontenot H, Whitmer A, Michel A Elife. 2023; 12.

PMID: 37664989 PMC: 10476963. DOI: 10.7554/eLife.86358.

References

Selby K, Jensen C, Levin T, Lee J, Schottinger J, Zhao W . Program Components and Results From an Organized Colorectal Cancer Screening Program Using Annual Fecal Immunochemical Testing. Clin Gastroenterol Hepatol. 2020; 20(1):145-152. PMC: 7526597. DOI: 10.1016/j.cgh.2020.09.042. View

Richards T, Lindley M, Byron S, Saraiya M . Human papilloma virus vaccination and cervical cancer screening coverage in managed care plans - United States, 2018. Prev Med. 2022; 159:107019. PMC: 9117512. DOI: 10.1016/j.ypmed.2022.107019. View

Brisson M, Kim J, Canfell K, Drolet M, Gingras G, Burger E . Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020; 395(10224):575-590. PMC: 7043009. DOI: 10.1016/S0140-6736(20)30068-4. View

Matz M, Weir H, Alkhalawi E, Coleman M, Allemani C . Disparities in cervical cancer survival in the United States by race and stage at diagnosis: An analysis of 138,883 women diagnosed between 2001 and 2014 (CONCORD-3). Gynecol Oncol. 2021; 163(2):305-311. PMC: 11075792. DOI: 10.1016/j.ygyno.2021.08.015. View

. Overcoming Barriers to Low HPV Vaccine Uptake in the United States: Recommendations from the National Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on June 9, 2015. Public Health Rep. 2016; 131(1):17-25. PMC: 4716467. DOI: 10.1177/003335491613100106. View

Suk R, Hong Y, Rajan S, Xie Z, Zhu Y, Spencer J . Assessment of US Preventive Services Task Force Guideline-Concordant Cervical Cancer Screening Rates and Reasons for Underscreening by Age, Race and Ethnicity, Sexual Orientation, Rurality, and Insurance, 2005 to 2019. JAMA Netw Open. 2022; 5(1):e2143582. PMC: 8767443. DOI: 10.1001/jamanetworkopen.2021.43582. View

Pingali C, Yankey D, Elam-Evans L, Markowitz L, Williams C, Fredua B . National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020. MMWR Morb Mortal Wkly Rep. 2021; 70(35):1183-1190. PMC: 8422873. DOI: 10.15585/mmwr.mm7035a1. View

Lozar T, Nagvekar R, Rohrer C, Dube Mandishora R, Ivanus U, Fitzpatrick M . Cervical Cancer Screening Postpandemic: Self-Sampling Opportunities to Accelerate the Elimination of Cervical Cancer. Int J Womens Health. 2021; 13:841-859. PMC: 8458024. DOI: 10.2147/IJWH.S288376. View

Wentzensen N, Clarke M, Perkins R . Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities. Prev Med. 2021; 151:106596. PMC: 8241689. DOI: 10.1016/j.ypmed.2021.106596. View

10.

Castle P, Rausa A, Walls T, Gravitt P, Partridge E, Olivo V . Comparative community outreach to increase cervical cancer screening in the Mississippi Delta. Prev Med. 2011; 52(6):452-5. PMC: 3114876. DOI: 10.1016/j.ypmed.2011.03.018. View

11.

Benard V, Jackson J, Greek A, Senkomago V, Huh W, Thomas C . A population study of screening history and diagnostic outcomes of women with invasive cervical cancer. Cancer Med. 2021; 10(12):4127-4137. PMC: 8209614. DOI: 10.1002/cam4.3951. View

12.

Mix J, Van Dyne E, Saraiya M, Hallowell B, Thomas C . Assessing Impact of HPV Vaccination on Cervical Cancer Incidence among Women Aged 15-29 Years in the United States, 1999-2017: An Ecologic Study. Cancer Epidemiol Biomarkers Prev. 2020; 30(1):30-37. PMC: 7855406. DOI: 10.1158/1055-9965.EPI-20-0846. View

13.

Sinsky C, Brown R, Stillman M, Linzer M . COVID-Related Stress and Work Intentions in a Sample of US Health Care Workers. Mayo Clin Proc Innov Qual Outcomes. 2021; 5(6):1165-1173. PMC: 8651505. DOI: 10.1016/j.mayocpiqo.2021.08.007. View

14.

. ACOG Committee Opinion No. 586: Health disparities in rural women. Obstet Gynecol. 2014; 123(2 Pt 1):384-388. DOI: 10.1097/01.AOG.0000443278.06393.d6. View

15.

Fuzzell L, Perkins R, Christy S, Lake P, Vadaparampil S . Cervical cancer screening in the United States: Challenges and potential solutions for underscreened groups. Prev Med. 2021; 144:106400. DOI: 10.1016/j.ypmed.2020.106400. View

16.

Bishop E, Katz M, Reiter P . Acceptability of Human Papillomavirus Self-Sampling Among a National Sample of Women in the United States. Biores Open Access. 2019; 8(1):65-73. PMC: 6497327. DOI: 10.1089/biores.2018.0040. View